2025. CARDIOVASCULAR RISK FEATURES IN PATIENTS WITH METABOLIC-ASSOCIATED FATTY LIVER DISEASE (MAFLD) DEPENDING ON THE PRESENCE OF OBESITY. International journal of medical sciences. 5, 05 (Jun. 2025), 396–403. DOI:https://doi.org/10.55640/.